论文部分内容阅读
目的探究奥曲肽治疗肝硬化合并消化道出血258例患者的临床效果。方法从本院2010年5月至2015年4月期间收治的肝硬化合并消化道出血患者中选取258例作为研究对象,采用数字表法随机分为观察组130例和对照组128例,观察组给予奥曲肽治疗,对照组给予垂体后叶素治疗,观察比较两组临床疗效。结果观察组总有效率优于对照组,差异存在统计学意义(P<0.05);观察组再次出血率、并发症发生率均低于对照组,差异存在统计学意义(P<0.05)。结论对肝硬化合并消化道出血患者使用奥曲肽进行临床治疗,能够取得明显的临床效果,并发症减少,值得应用。
Objective To investigate the clinical effect of octreotide on 258 patients with cirrhosis and gastrointestinal hemorrhage. Methods From May 2010 to April 2015 in our hospital selected 258 cases of patients with cirrhosis and gastrointestinal bleeding were selected as the object of study, the use of digital table were randomly divided into observation group 130 cases and control group 128 cases, the observation group Give octreotide treatment, the control group given pituitrin treatment, observed and compared the clinical efficacy of the two groups. Results The total effective rate of the observation group was better than that of the control group (P <0.05). The rebleeding rate and the complication rate of the observation group were lower than those of the control group (P <0.05). Conclusion The clinical treatment of patients with cirrhosis and gastrointestinal bleeding using octreotide can achieve obvious clinical effects and reduce complications, which is worthy of application.